The expression of Dicer and Drosha in matched normal tissues, tumours and lymph node metastases in triple negative breast cancer
1 Centre for Information-Based Medicine, Hunter Medical Research Institute, John Hunter Hospital, New Lambton Heights, NSW 2305, Australia
2 School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle, Callaghan, NSW 2308, Australia
3 Hunter Area Pathology Service, John Hunter Hospital, New Lambton Heights, NSW 2305, Australia
4 Australian New Zealand Breast Cancer Trials Group and, Department of Surgical Oncology, Calvary Mater Newcastle Hospital, Waratah, NSW 2298, Australia
5 School of Medicine and Public Health, Faculty of Health, University of Newcastle, Callaghan, NSW 2308, Australia
BMC Cancer 2014, 14:253 doi:10.1186/1471-2407-14-253Published: 11 April 2014
Breast cancer is the most common malignancy in women world-wide. Triple negative breast cancer (TNBC) is a highly aggressive subtype that lacks expression of hormone receptors for estrogen, progesterone and human epidermal growth factor 2; and is associated with a high propensity for metastatic spread. Several studies have identified critical roles for microRNAs in breast cancer, but the role of two critical enzymes involved in microRNA biogenesis, Dicer and Drosha, is not well understood, particularly with respect to metastatic progression in this subtype.
We examined the expression of Dicer and Drosha in a series of invasive 35 TNBCs with matched normal adjacent tissues (n = 18) and lymph node metastases (n = 15) using semi-quantitative real time RT-PCR. The relationship of their expression with clinical features including age at diagnosis, lymph node positivity and tumour size was analysed.
We report that Dicer was significantly decreased while Drosha was significantly increased in tumours when compared to normal adjacent tissues. While there was no difference in Drosha expression in lymph node metastases when compared to the primary tumour, Dicer was significantly increased. There was no correlation between the expression of either Dicer or Drosha to age at diagnosis, lymph node positivity and tumour size.
In conclusion, Dicer and Drosha are dysregulated in TNBC and matched lymph node metastases however, the clinical relevance of this is still not known. The altered expression of Dicer and Drosha may serve as markers for disrupted miRNA biogenesis in TNBC.